Acceleration of the Glycolytic Flux by Steroid Receptor Coactivator-2 Is Essential for Endometrial Decidualization
Early embryo miscarriage is linked to inadequate endometrial decidualization, a cellular transformation process that enables deep blastocyst invasion into the maternal compartment. Although much of the cellular events that underpin endometrial stromal cell (ESC) decidualization are well recognized, the individual gene(s) and molecular pathways that drive the initiation and progression of this process remain elusive. Using a genetic mouse model and a primary human ESC culture model, we demonstrate that steroid receptor coactivator-2 (SRC-2) is indispensable for rapid steroid hormone-dependent proliferation of ESCs, a critical cell-division step which precedes ESC terminal differentiation into decidual cells. We reveal that SRC-2 is required for increasing the glycolytic flux in human ESCs, which enables rapid proliferation to occur during the early stages of the decidualization program. Specifically, SRC-2 increases the glycolytic flux through induction of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3 (PFKFB3), a major rate-limiting glycolytic enzyme. Similarly, acute treatment of mice with a small molecule inhibitor of PFKFB3 significantly suppressed the ability of these animals to exhibit an endometrial decidual response. Together, these data strongly support a conserved mechanism of action by which SRC-2 accelerates the glycolytic flux through PFKFB3 induction to provide the necessary bioenergy and biomass to meet the demands of a high proliferation rate observed in ESCs prior to their differentiation into decidual cells. Because deregulation of endometrial SRC-2 expression has been associated with common gynecological disorders of reproductive-age women, this signaling pathway, involving SRC-2 and PFKFB3, promises to offer new clinical approaches in the diagnosis and/or treatment of a non-receptive uterus in patients presenting idiopathic infertility, recurrent early pregnancy loss, or increased time to pregnancy.
Vyšlo v časopise:
Acceleration of the Glycolytic Flux by Steroid Receptor Coactivator-2 Is Essential for Endometrial Decidualization. PLoS Genet 9(10): e32767. doi:10.1371/journal.pgen.1003900
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1003900
Souhrn
Early embryo miscarriage is linked to inadequate endometrial decidualization, a cellular transformation process that enables deep blastocyst invasion into the maternal compartment. Although much of the cellular events that underpin endometrial stromal cell (ESC) decidualization are well recognized, the individual gene(s) and molecular pathways that drive the initiation and progression of this process remain elusive. Using a genetic mouse model and a primary human ESC culture model, we demonstrate that steroid receptor coactivator-2 (SRC-2) is indispensable for rapid steroid hormone-dependent proliferation of ESCs, a critical cell-division step which precedes ESC terminal differentiation into decidual cells. We reveal that SRC-2 is required for increasing the glycolytic flux in human ESCs, which enables rapid proliferation to occur during the early stages of the decidualization program. Specifically, SRC-2 increases the glycolytic flux through induction of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3 (PFKFB3), a major rate-limiting glycolytic enzyme. Similarly, acute treatment of mice with a small molecule inhibitor of PFKFB3 significantly suppressed the ability of these animals to exhibit an endometrial decidual response. Together, these data strongly support a conserved mechanism of action by which SRC-2 accelerates the glycolytic flux through PFKFB3 induction to provide the necessary bioenergy and biomass to meet the demands of a high proliferation rate observed in ESCs prior to their differentiation into decidual cells. Because deregulation of endometrial SRC-2 expression has been associated with common gynecological disorders of reproductive-age women, this signaling pathway, involving SRC-2 and PFKFB3, promises to offer new clinical approaches in the diagnosis and/or treatment of a non-receptive uterus in patients presenting idiopathic infertility, recurrent early pregnancy loss, or increased time to pregnancy.
Zdroje
1. CarsonDD, BagchiI, DeySK, EndersAC, FazleabasAT, et al. (2000) Embryo implantation. Dev Biol 223: 217–237.
2. NorwitzER, SchustDJ, FisherSJ (2001) Implantation and the survival of early pregnancy. N Engl J Med 345: 1400–1408.
3. WilcoxAJ, BairdDD, WeinbergCR (1999) Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340: 1796–1799.
4. ChaJ, SunX, DeySK (2012) Mechanisms of implantation: strategies for successful pregnancy. Nat Med 18: 1754–1767.
5. DiedrichK, FauserBC, DevroeyP, GriesingerG (2007) Evian Annual Reproduction Workshop G (2007) The role of the endometrium and embryo in human implantation. Hum Reprod Update 13: 365–377.
6. StrowitzkiT, GermeyerA, PopoviciR, von WolffM (2006) The human endometrium as a fertility-determining factor. Hum Reprod Update 12: 617–630.
7. DasSK (2009) Cell cycle regulatory control for uterine stromal cell decidualization in implantation. Reproduction 137: 889–899.
8. SrogaJM, MaX, DasSK (2012) Developmental regulation of decidual cell polyploidy at the site of implantation. Front Biosci (Schol Ed) 4: 1475–1486.
9. FinnCA, MartinL (1972) Endocrine control of the timing of endometrial sensitivity to a decidual stimulus. Biol Reprod 7: 82–86.
10. XuJ, WuRC, O'MalleyBW (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615–630.
11. MukherjeeA, AmatoP, AllredDC, DeMayoFJ, LydonJP (2007) Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human. Nucl Recept Signal 5: e011.
12. MukherjeeA, SoyalSM, Fernandez-ValdiviaR, GehinM, ChambonP, et al. (2006) Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol Cell Biol 26: 6571–6583.
13. GregoryCW, WilsonEM, ApparaoKB, LiningerRA, MeyerWR, et al. (2002) Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 87: 2960–2966.
14. CondonJC, JeyasuriaP, FaustJM, WilsonJW, MendelsonCR (2003) A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 100: 9518–9523.
15. KonnoT, GrahamAR, RempelLA, Ho-ChenJK, AlamSM, et al. (2010) Subfertility linked to combined luteal insufficiency and uterine progesterone resistance. Endocrinology 151: 4537–4550.
16. YinP, LinZ, ReierstadS, WuJ, IshikawaH, et al. (2010) Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res 70: 1722–1730.
17. ChopraAR, KommaganiR, SahaP, LouetJF, SalazarC, et al. (2011) Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab 13: 35–43.
18. ChopraAR, LouetJF, SahaP, AnJ, DemayoF, et al. (2008) Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322: 1395–1399.
19. YorkB, O'MalleyBW (2010) Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem 285: 38743–38750.
20. TongW, PollardJW (1999) Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19: 2251–2264.
21. FrancoHL, DaiD, LeeKY, RubelCA, RoopD, et al. (2011) WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J 25: 1176–1187.
22. HuyenDV, BanyBM (2011) Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization. Reproduction 142: 353–368.
23. LeeKY, JeongJW, WangJ, MaL, MartinJF, et al. (2007) Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27: 5468–5478.
24. LiQ, KannanA, DeMayoFJ, LydonJP, CookePS, et al. (2011) The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science 331: 912–916.
25. BrosensJJ, HayashiN, WhiteJO (1999) Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 140: 4809–4820.
26. BrosensJJ, TakedaS, AcevedoCH, LewisMP, KirbyPL, et al. (1996) Human endometrial fibroblasts immortalized by simian virus 40 large T antigen differentiate in response to a decidualization stimulus. Endocrinology 137: 2225–2231.
27. DeBerardinisRJ, LumJJ, HatzivassiliouG, ThompsonCB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11–20.
28. LuntSY, Vander HeidenMG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441–464.
29. Vander HeidenMG, CantleyLC, ThompsonCB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029–1033.
30. Vander HeidenMG, LuntSY, DaytonTL, FiskeBP, IsraelsenWJ, et al. (2011) Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol 76: 325–334.
31. MetalloCM, Vander HeidenMG (2013) Understanding metabolic regulation and its influence on cell physiology. Mol Cell 49: 388–398.
32. YorkB, SagenJV, TsimelzonA, LouetJF, ChopraAR, et al. (2013) Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Mol Endocrinol 27: 366–380.
33. LouetJF, ChopraAR, SagenJV, AnJ, YorkB, et al. (2010) The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab 12: 606–618.
34. FrolovaAI, MoleyKH (2011) Quantitative analysis of glucose transporter mRNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology 152: 2123–2128.
35. FrolovaAI, O'NeillK, MoleyKH (2011) Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation. Mol Endocrinol 25: 1444–1455.
36. HacklH (1973) Metabolism of glucose in the human endometrium with special reference to fertility and contraception. Acta Obstet Gynecol Scand 52: 135–140.
37. von WolffM, UrselS, HahnU, SteldingerR, StrowitzkiT (2003) Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 88: 3885–3892.
38. YalcinA, TelangS, ClemB, ChesneyJ (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86: 174–179.
39. WuM, NeilsonA, SwiftAL, MoranR, TamagnineJ, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–136.
40. ClemB, TelangS, ClemA, YalcinA, MeierJ, et al. (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110–120.
41. ChesneyJ (2006) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 9: 535–539.
42. ChesneyJ, TelangS, YalcinA, ClemA, WallisN, et al. (2005) Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality. Biochem Biophys Res Commun 331: 139–146.
43. GalassiL (1968) Autoradiographic study of the decidual cell reaction in the rat. Dev Biol 17: 75–84.
44. GermeyerA, von WolffM, JauckusJ, StrowitzkiT, SharmaT, et al. (2010) Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures–a pilot study. Reprod Biol Endocrinol 8: 67.
45. MoultonBC, BarkerKL (1974) Effects of 8-azaguanine on the induction of uterine glucose-6-phosphate dehydrogenase activity by estradiol or NADP plus. Proc Soc Exp Biol Med 146: 742–746.
46. SuraniMA, HealdPJ (1971) Changes in enzymes of carbohydrate metabolism in rat uterus during early pregnancy. Acta Endocrinol (Copenh) 68: 805–816.
47. SuraniMA, HealdPJ (1971) The metabolism of glucose by rat uterus tissue in early pregnancy. Acta Endocrinol (Copenh) 66: 16–24.
48. HamiltonJA, CallaghanMJ, SutherlandRL, WattsCKW (1997) Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase. Mol Endo 11: 490–502.
49. NovellasdemuntL, ObachM, Millan-ArinoL, ManzanoA, VenturaF, et al. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells. Biochem J 442: 345–356.
50. AtsumiT, ChesneyJ, MetzC, LengL, DonnellyS, et al. (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881–5887.
51. MarottaLL, AlmendroV, MarusykA, ShipitsinM, SchemmeJ, et al. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(−) stem cell-like breast cancer cells in human tumors. J Clin Invest 121: 2723–2735.
52. MinchenkoA, LeshchinskyI, OpentanovaI, SangN, SrinivasV, et al. (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277: 6183–6187.
53. ReddyMM, FernandesMS, DeshpandeA, WeisbergE, InguilizianHV, et al. (2012) The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. Leukemia 26: 481–489.
54. Rodriguez-RodriguezP, FernandezE, AlmeidaA, BolanosJP (2012) Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ 19: 1582–1589.
55. TelangS, YalcinA, ClemAL, BucalaR, LaneAN, et al. (2006) Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 25: 7225–7234.
56. FukasawaM, TsuchiyaT, TakayamaE, ShinomiyaN, UyedaK, et al. (2004) Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biochem 136: 273–277.
57. SoyalSM, MukherjeeA, LeeKY, LiJ, LiH, et al. (2005) Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41: 58–66.
58. GehinM, MarkM, DennefeldC, DierichA, GronemeyerH, et al. (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22: 5923–5937.
59. WMA Declaration of Helsinki Serves as Guide to Physicians. Calif Med 105: 149–150.
60. KhokharSK, KommaganiR, KadakiaMP (2008) Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes. Cell Res 18: 1061–1073.
61. MukherjeeA, SoyalSM, LiJ, YingY, SzwarcMM, et al. (2011) A mouse transgenic approach to induce beta-catenin signaling in a temporally controlled manner. Transgenic Res 20: 827–840.
62. PutluriN, ShojaieA, VasuVT, NalluriS, VareedSK, et al. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells. PLoS One 6: e21417.
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2013 Číslo 10
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Dominant Mutations in Identify the Mlh1-Pms1 Endonuclease Active Site and an Exonuclease 1-Independent Mismatch Repair Pathway
- Eleven Candidate Susceptibility Genes for Common Familial Colorectal Cancer
- The Histone H3 K27 Methyltransferase KMT6 Regulates Development and Expression of Secondary Metabolite Gene Clusters
- A Mutation in the Gene in Labrador Retrievers with Hereditary Nasal Parakeratosis (HNPK) Provides Insights into the Epigenetics of Keratinocyte Differentiation